Alkermes Announces FDA Acceptance for Review of New Drug Application for ALKS 5461 for the Adjunctive Treatment ... - Markets Insider

Alkermes Announces FDA Acceptance for Review of New Drug Application for ALKS 5461 for the Adjunctive Treatment ...Markets InsiderFDA Action Expected by Jan. 31, 2019 --. -- Conference Call Scheduled for Today at 8:30 a.m. ET --. DUBLIN, April 16, 2018 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has accepted for ...and more »